Eris Lifesciences Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

NEGATIVES

Declining net profit margin of 2% suggests rising costs are impacting profitability.
Increased debt levels may raise concerns about financial stability in future quarters.
Slowdown in sales volume growth compared to previous periods may indicate market saturation.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	505.30	486.30	550.92	719.72	741.17	727.45	705.30	773
Expenses	382.54	374.62	489.43	606.04	616.61	615.51	584.44	615.48
Operating Profit	122.75	111.68	61.50	113.68	124.56	111.94	120.86	157.52
Other Income	3.48	4.20	15.15	1.64	4.55	4.22	7.95	2.69
Interest	16.29	18.12	33.03	60.37	59.47	57.17	54.28	48.68
Depreciation	42.09	45.72	53.90	75.94	80.48	81.20	77.25	70.51
Profit Before Tax	126.24	115.87	76.65	115.32	129.11	116.16	128.87	161.10
Tax	3.92	14.41	-2.99	25.90	32.76	29.23	26.52	36
Net Profit	122.31	101.46	79.63	89.42	96.35	86.93	102.35	125.10
Eps in Rs	9.08	7.55	5.22	6.11	6.73	6.15	6.90	8.66